231 related articles for article (PubMed ID: 24424703)
21. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Taurah L; Chandler C; Sanders G
Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
[TBL] [Abstract][Full Text] [Related]
22. 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content.
Wardle MC; Kirkpatrick MG; de Wit H
Soc Cogn Affect Neurosci; 2014 Aug; 9(8):1076-81. PubMed ID: 24682132
[TBL] [Abstract][Full Text] [Related]
23. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI.
Schouw ML; Gevers S; Caan MW; Majoie CB; Booij J; Nederveen AJ; Reneman L
Eur Neuropsychopharmacol; 2012 Aug; 22(8):537-45. PubMed ID: 22209360
[TBL] [Abstract][Full Text] [Related]
24. MDMA (ecstasy) delays pubertal development and alters sperm quality after developmental exposure in the rat.
Barenys M; Gomez-Catalan J; Camps L; Teixido E; de Lapuente J; Gonzalez-Linares J; Serret J; Borras M; Rodamilans M; Llobet JM
Toxicol Lett; 2010 Aug; 197(2):135-42. PubMed ID: 20546852
[TBL] [Abstract][Full Text] [Related]
25. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
26. Motor delays in MDMA (ecstasy) exposed infants persist to 2 years.
Singer LT; Moore DG; Min MO; Goodwin J; Turner JJ; Fulton S; Parrott AC
Neurotoxicol Teratol; 2016; 54():22-8. PubMed ID: 26806601
[TBL] [Abstract][Full Text] [Related]
27. Memory deficits associated with recreational use of "ecstasy" (MDMA).
Morgan MJ
Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
[TBL] [Abstract][Full Text] [Related]
28. Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.
Parrott AC; Milani RM; Gouzoulis-Mayfrank E; Daumann J
J Neural Transm (Vienna); 2007; 114(8):959-68. PubMed ID: 17520319
[TBL] [Abstract][Full Text] [Related]
29. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
Parrott AC
Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
[TBL] [Abstract][Full Text] [Related]
30. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature.
Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M
Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622
[TBL] [Abstract][Full Text] [Related]
31. Diurnal salivary cortisol patterns prior to pregnancy predict infant birth weight.
Guardino CM; Schetter CD; Saxbe DE; Adam EK; Ramey SL; Shalowitz MU;
Health Psychol; 2016 Jun; 35(6):625-33. PubMed ID: 26844584
[TBL] [Abstract][Full Text] [Related]
32. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).
Ho E; Karimi-Tabesh L; Koren G
Neurotoxicol Teratol; 2001; 23(6):561-7. PubMed ID: 11792525
[TBL] [Abstract][Full Text] [Related]
34. Recreational 3,4-methylenedioxymethamphetamine or 'ecstasy': Current perspective and future research prospects.
Parrott AC; Downey LA; Roberts CA; Montgomery C; Bruno R; Fox HC
J Psychopharmacol; 2017 Aug; 31(8):959-966. PubMed ID: 28661257
[TBL] [Abstract][Full Text] [Related]
35. Ecstasy (3,4-methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion.
Farah R; Farah R
Pediatr Emerg Care; 2008 Sep; 24(9):615-7. PubMed ID: 18797371
[TBL] [Abstract][Full Text] [Related]
36. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
Parrott AC; Lasky J
Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
[TBL] [Abstract][Full Text] [Related]
37. Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research.
Curran HV
Neuropsychobiology; 2000; 42(1):34-41. PubMed ID: 10867554
[TBL] [Abstract][Full Text] [Related]
38. Hair cortisol as a hypothalamic-pituitary-adrenal axis biomarker in pregnant women with asthma: a retrospective observational study.
Smy L; Shaw K; Amstutz U; Smith A; Berger H; Carleton B; Koren G
BMC Pregnancy Childbirth; 2016 Jul; 16(1):176. PubMed ID: 27440139
[TBL] [Abstract][Full Text] [Related]
39. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
Parrott AC; Lees A; Garnham NJ; Jones M; Wesnes K
J Psychopharmacol; 1998; 12(1):79-83. PubMed ID: 9584971
[TBL] [Abstract][Full Text] [Related]
40. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Gouzoulis-Mayfrank E; Daumann J
J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
